$VMD

Smokoff Timothy sold $230K of VMD

Smokoff Timothy sold 20,000 shares of VIEMED HEALTHCARE, INC. (VMD) at an average of $11.50 ($11.41–$11.56, $0.23M total) across 5 trades on 2026-06-24.

Original reporting
SEC EDGAR · Smokoff Timothy
Published Jun 26, 2026, 4:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 6:59 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$VMD
Neutral
medium confidence
Mentioned
$VMD
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VMDNeutralLow
01

Why it matters

A director’s open-market sale of 20,000 shares at roughly $11.50 each is disclosed, totaling about $229,967, with holdings after the sale of 75,518 shares.

02

Market read

Traders may monitor VMD for any clustering of insider selling or changes in trading behavior, but there is no fundamental catalyst in the text.

03

What to watch

The article does not provide context on total holdings, prior sale cadence, or whether other insiders sold around the same time, which limits inference from a single transaction.

Relevance 4/10Novelty 3/10Timing: Filed 2026-06-26, reporting sales executed 2026-06-24.

Background

The article is a SEC Form 4 insider transaction disclosure for VIEMED HEALTHCARE, Inc. (VMD).

Company-level read

Ticker impact

$VMDNeutralMedium confidence
Context

VIEMED HEALTHCARE director Smokoff Timothy sold about $229,967 of VMD shares in open-market transactions at $11.41 to $11.56.

Expected impact

Likely limited, short-lived sentiment impact; watch for follow-on selling or unusual volume around the sale window.

Evidence & confidence

This is a routine Form 4 insider transaction with no 10b5-1 plan stated and no accompanying company-specific news (earnings, guidance, deals, or regulatory actions).

Market effects

No clear sector read-through; this is company-specific insider activity.

None indicated.

None indicated.

Counterpoint

Insider sales can be planned for diversification or liquidity needs; the absence of a stated 10b5-1 plan does not necessarily imply negative expectations.

Key entities

  • VIEMED HEALTHCARE, INC.

    Company whose director insider sale is disclosed via SEC Form 4.

  • Smokoff Timothy

    Director who sold 20,000 shares across five trades on 2026-06-24.

Related articles

$VMDMedAI 8/10

Viemed Healthcare Q2 Earnings Call Highlights

Viemed Healthcare (NASDAQ:VMD) reported Q2 updates on home respiratory and sleep therapies. Management cited improved ventilator patient growth and said PAP setups rose, with sleep patients up about 5% sequentially and 44% YoY. Equipment sales nearly doubled to $19M. Gross profit was $45M (57.7% margin). Full-year net revenue guidance raised to $314M-$320M and adjusted EBITDA to $64M-$68M.

$VMDHigh

VIEMED HEALTHCARE, INC. (VMD): Results of Operations and Financial Condition

VIEMED HEALTHCARE, INC. (VMD) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 q22026earningsrelease.htm EX-99.1 Document VIEMED HEALTHCARE ANNOUNCES SECOND QUARTER 2026 FINANCIAL RESULTS Lafayette, Louisiana (August 3, 2026) Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national provider of technology-enabled, home-based hea